In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei | Zendy

Leslie R. Ashdown | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei

Author(s) -

Leslie R. Ashdown

Publication year - 1988

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.32.9.1435

Subject(s) - ticarcillin , piperacillin , cefotaxime , ceftazidime , microbiology and biotechnology , clavulanic acid , imipenem , ciprofloxacin , azlocillin , antimicrobial , norfloxacin , pseudomonas , quinolone , antibacterial agent , biology , amoxicillin , antibiotics , pseudomonas aeruginosa , bacteria , antibiotic resistance , genetics

Imipenem was highly active and bactericidal against all 100 strains of Pseudomonas pseudomallei tested, followed in activity by piperacillin, carumonam, ceftazidime, cefotaxime, and ceftriaxone. The addition of clavulanic acid significantly increased the activities of both amoxicillin and ticarcillin. Ciprofloxacin and norfloxacin showed poor activity against test strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research